Analysis of 312 studies of investigational medicinal products in healthy subjects to assess the impact of the European Union Clinical Trials Directive

Author： Malcolm B.   Steve W.  

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.16, Iss.4, 2002-08, pp. : 179-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulation of clinical trials in the European Union: new regime

By N S.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 3, 2001-06 ,pp. : 121-123

Adis International

Access to resources Recommend Favorite

On the critical assessment of the impact of the recent European Union Tissues and Cells Directive

By Bhargava Pushpa M  

Reproductive BioMedicine Online, Vol. 11, Iss. 2, 2005-08 ,pp. : 161-161

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Impact of the Clinical Trials Directive on the Research-Based Pharmaceutical Industry

By Moira Daniels  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 1, 2004-01 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Interpersonal Values of Healthy Subjects Who Volunteer for Phase I Clinical Trials

By Almeida Luis   Vaz-da-Silva Manuel  

Pharmaceutical Medicine, Vol. 23, Iss. 5-6, 2009-10 ,pp. : 299-303

Adis International

Access to resources Recommend Favorite

The European Clinical Trials Directive: Will it Promote Clinical Research in Europe?

By Richard Tiner  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 1, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite